GlassScriptPhysician profile
Mychael Luu
NPI 1093718546
$35,022.06
in general payments reported to CMS, 2019-2025
39 companies · $7,213 in 2025
The $7,213 reported for 2025 was more than what 91% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,332 · 2020: $3,661 · 2021: $3,763 · 2022: $3,394 · 2023: $6,144 · 2024: $6,515 · 2025: $7,213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19K · Education: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19,183.94 |
| Education | $688.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,375.64 | 2019-2025 | |
| Janssen Biotech, INC. | $3,596.83 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Regeneron Healthcare Solutions, INC. | $3,119.35 | 2019-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $2,354.70 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Novartis Pharmaceuticals Corporation | $2,344.12 | 2019-2025 | |
| Leo Pharma INC. | $2,092.15 | 2019-2025 | Adbry, Anzupgo |
| Genzyme Corporation | $1,980.57 | 2019-2025 | |
| Galderma Laboratories, L.P. | $1,864.31 | 2019-2025 | Nemluvio |
| Sun Pharmaceutical Industries INC. | $1,696.46 | 2019-2025 | Absorica Ld, Winlevi, Ilumya |
| Ucb, INC. | $1,589.91 | 2019-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $1,478.40 | 2019-2025 | |
| Incyte Corporation | $1,309.80 | 2021-2025 | Opzelura, Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $1,284.00 | 2019-2025 | Siliq, Duobrii, Cabtreo |
| Amgen INC. | $938.62 | 2019-2024 | Otezla |
| E.R. Squibb & Sons, L.L.C. | $882.19 | 2022-2025 | Sotyktu |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mychael Luu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.